![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS No 6134w CELSIS INTERNATIONAL PLC 20th May 1998 CELSIS INTERNATIONAL PLC ("the Company") Application has been made to the London Stock Exchange for 79,696 Ordinary Shares of 1p each to be admitted to the Official List. These shares, ranking pari passu in all respects with the existing shares in issue, have been allotted to Mr R.T. Hollis who is entitled to a 1998 Earn Out payment, equivalent to US$ 50,000, in connection with the acquisition of Scientific Associates Inc Copies of this announcement may be obtained from the Company's Registered Office for a period of 14 days and at the Company Announcements Office of the London Stock Exchange for a period of 2 days following this announcement (collection only). END LISGBUCUABGRGGR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions